The immunohistochemical trio of CDK4, MDM2, and p16 is a useful ancillary diagnostic tool that provides strong support for distinguishing differentiated liposarcoma from other adipocytic neoplasms [10]. This evidence concerns the gene CDK4 and liposarcoma.